TNFRSF1B and neoplasm: In addition, TNFR2-targeted inhibitors may eliminate not only cancer cells, but also Tregs, which will contribute to immunosuppression and may help to restore the suppressed tumour killing ability of effector T cells [64,70,71,83,84].